Cargando…
K15 promoter-driven enforced expression of NKIRAS exhibits tumor suppressive activity against the development of DMBA/TPA-induced skin tumors
NKIRAS1 and NKIRAS2 (also called as κB-Ras) were identified as members of the atypical RAS family that suppress the transcription factor NF-κB. However, their function in carcinogenesis is still controversial. To clarify how NKIRAS acts on cellular transformation, we generated transgenic mice in whi...
Autores principales: | Tago, Kenji, Ohta, Satoshi, Aoki-Ohmura, Chihiro, Funakoshi-Tago, Megumi, Sashikawa, Miho, Matsui, Takeshi, Miyamoto, Yuki, Wada, Taeko, Oshio, Tomoyuki, Komine, Mayumi, Matsugi, Jitsuhiro, Furukawa, Yusuke, Ohtsuki, Mamitaro, Yamauchi, Junji, Yanagisawa, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526694/ https://www.ncbi.nlm.nih.gov/pubmed/34667224 http://dx.doi.org/10.1038/s41598-021-00200-1 |
Ejemplares similares
-
STAT3 and ERK pathways are involved in cell growth stimulation of the ST2/IL1RL1 promoter
por: Tago, Kenji, et al.
Publicado: (2017) -
ST2 gene products critically contribute to cellular transformation caused by an oncogenic Ras mutant
por: Tago, Kenji, et al.
Publicado: (2017) -
Oncogenic Ras mutant causes the hyperactivation of NF‐κB via acceleration of its transcriptional activation
por: Tago, Kenji, et al.
Publicado: (2019) -
EBP2, a novel NPM‐ALK‐interacting protein in the nucleolus, contributes to the proliferation of ALCL cells by regulating tumor suppressor p53
por: Uchihara, Yuki, et al.
Publicado: (2020) -
Drug Survival of Tumor Necrosis Factor-Alpha Inhibitors and Switched Subsequent Biologic Agents in Patients with Psoriasis: A Retrospective Study
por: Kishimoto, Megumi, et al.
Publicado: (2023)